• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN AND SHURTLEFF, INC STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN AND SHURTLEFF, INC STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISEENC
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Edema (1820)
Event Date 04/30/2019
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the no lot number was provided by the customer.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.  information regarding patient weight, height, medical history, race, and ethnicity was not reported.Cerenovus manufacturer's report numbers: 1226348-2020-00048.Are related to the same incident.
 
Event Description
This complaint is from a literature source.As reported in the literature publication entitled ¿use of intracranial stent as rescue therapy after mechanical thrombectomy failure¿9-year experience in a comprehensive stroke centre¿ ascular treatment for acute stroke experienced symptomatic intracranial haemorrhage.1 patient with large vessel occlusion in distal internal carotid artery or proximal middle cerebral artery who underwent endovascular treatment for acute stroke experienced cerebral oedema.Purpose there is no established rescue treatment in patients with mechanical thrombectomy (mt) failure.Our aim is to analyses whether the use of an intracranial stent improves prognosis in these patients.Methods: retrospective analysis of a prospective cohort of patients with ischemic stroke due to middle cerebral artery occlusion (mca) or distal intracranial carotid artery (ica) occlusion, from september 2009 to april 2019.Patients with mt failure were identified and dichotomized into two groups according to whether or not an intracranial stent was implanted.We analysed clinical outcomes in both groups.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STENT - VASCULAR RECONSTRUCTION
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
Manufacturer (Section G)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key10368070
MDR Text Key203893650
Report Number1226348-2020-00047
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
PMA/PMN Number
UNK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial
Report Date 07/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/05/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISEENC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/15/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age62 YR
-
-